Castle Biosciences, Inc.

NasdaqGM:CSTL 주식 보고서

시가총액: US$796.8m

Castle Biosciences 관리

관리 기준 확인 4/4

Castle Biosciences CEO는 Derek Maetzold, Sep2007 에 임명되었습니다 의 임기는 17.17 년입니다. 총 연간 보상은 $ 1.61M, 42.7% 로 구성됩니다. 42.7% 급여 및 57.3% 보너스(회사 주식 및 옵션 포함). 는 $ 11.38M 가치에 해당하는 회사 주식의 1.43% 직접 소유합니다. 11.38M. 경영진과 이사회의 평균 재임 기간은 각각 4.3 년과 4 년입니다.

주요 정보

Derek Maetzold

최고 경영자

US$1.6m

총 보상

CEO 급여 비율42.7%
CEO 임기17.2yrs
CEO 소유권1.4%
경영진 평균 재임 기간4.3yrs
이사회 평균 재임 기간4yrs

최근 관리 업데이트

Recent updates

Are Investors Undervaluing Castle Biosciences, Inc. (NASDAQ:CSTL) By 49%?

Oct 15
Are Investors Undervaluing Castle Biosciences, Inc. (NASDAQ:CSTL) By 49%?

Castle Biosciences: Inflection Into Profitability

Aug 16

Upgrade: Analysts Just Made A Meaningful Increase To Their Castle Biosciences, Inc. (NASDAQ:CSTL) Forecasts

Aug 11
Upgrade: Analysts Just Made A Meaningful Increase To Their Castle Biosciences, Inc. (NASDAQ:CSTL) Forecasts

Castle Biosciences, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates

Aug 08
Castle Biosciences, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates

Castle Biosciences, Inc.'s (NASDAQ:CSTL) 28% Share Price Surge Not Quite Adding Up

Aug 04
Castle Biosciences, Inc.'s (NASDAQ:CSTL) 28% Share Price Surge Not Quite Adding Up

Is Castle Biosciences (NASDAQ:CSTL) A Risky Investment?

Jul 12
Is Castle Biosciences (NASDAQ:CSTL) A Risky Investment?

Castle Biosciences, Inc.'s (NASDAQ:CSTL) P/S Is On The Mark

Apr 30
Castle Biosciences, Inc.'s (NASDAQ:CSTL) P/S Is On The Mark

Investors Appear Satisfied With Castle Biosciences, Inc.'s (NASDAQ:CSTL) Prospects

Jan 27
Investors Appear Satisfied With Castle Biosciences, Inc.'s (NASDAQ:CSTL) Prospects

Castle Biosciences (NASDAQ:CSTL) Is In A Good Position To Deliver On Growth Plans

Oct 31
Castle Biosciences (NASDAQ:CSTL) Is In A Good Position To Deliver On Growth Plans

Earnings Working Against Castle Biosciences, Inc.'s (NASDAQ:CSTL) Share Price Following 36% Dive

Jun 13
Earnings Working Against Castle Biosciences, Inc.'s (NASDAQ:CSTL) Share Price Following 36% Dive

Analysts Just Published A Bright New Outlook For Castle Biosciences, Inc.'s (NASDAQ:CSTL)

Aug 14
Analysts Just Published A Bright New Outlook For Castle Biosciences, Inc.'s (NASDAQ:CSTL)

Castle Biosciences Q2 2022 Earnings Preview

Aug 08

CEO 보상 분석

Derek Maetzold 의 보수는 Castle Biosciences 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

US$6m

Jun 30 2024n/an/a

-US$3m

Mar 31 2024n/an/a

-US$31m

Dec 31 2023US$2mUS$686k

-US$57m

Sep 30 2023n/an/a

-US$76m

Jun 30 2023n/an/a

-US$89m

Mar 31 2023n/an/a

-US$72m

Dec 31 2022US$8mUS$660k

-US$67m

Sep 30 2022n/an/a

-US$53m

Jun 30 2022n/an/a

-US$44m

Mar 31 2022n/an/a

-US$52m

Dec 31 2021US$7mUS$625k

-US$31m

Sep 30 2021n/an/a

-US$30m

Jun 30 2021n/an/a

-US$23m

Mar 31 2021n/an/a

-US$15m

Dec 31 2020US$5mUS$550k

-US$10m

Sep 30 2020n/an/a

-US$3m

Jun 30 2020n/an/a

US$7m

Mar 31 2020n/an/a

US$6m

Dec 31 2019US$4mUS$770k

US$3m

Sep 30 2019n/an/a

US$4m

Jun 30 2019n/an/a

-US$6m

Mar 31 2019n/an/a

-US$8m

Dec 31 2018US$791kUS$410k

-US$10m

보상 대 시장: Derek 의 총 보상 ($USD 1.61M ) US 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 3.20M ).

보상과 수익: Derek 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Derek Maetzold (62 yo)

17.2yrs

테뉴어

US$1,605,984

보상

Mr. Derek J. Maetzold founded Castle Biosciences Incorporated in September 2007 and serves as its President, Chief Executive Officer and Director since September 2007. He serves as the Director at AltheaDx...

리더십 팀

이름위치테뉴어보상소유권
Derek Maetzold
Founder17.2yrsUS$1.61m1.43%
$ 11.4m
Frank Stokes
CFO & Treasurer6.9yrsUS$880.25k0.15%
$ 1.2m
Kristen Oelschlager
Chief Operating Officer4.3yrsUS$828.48k0.48%
$ 3.8m
Tobin Juvenal
Chief Commercial Officer4.3yrsUS$829.10k0.20%
$ 1.6m
Camilla Zuckero
Vice President of Investor Relations & Corporate Affairsno data데이터 없음데이터 없음
Kevin Doman
Vice President of Sales2.4yrs데이터 없음데이터 없음
Keli Greenberg
VP of Human Resources & Executive Director of Human Resources4.3yrs데이터 없음데이터 없음
Matthew Goldberg
Senior Vice President of Medical1.5yrs데이터 없음데이터 없음
Bernhard Spiess
Company Secretaryno dataUS$1.69m데이터 없음

4.3yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 관리: CSTL 의 관리팀은 경험 ( 4.3 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Derek Maetzold
Founder17.2yrsUS$1.61m1.43%
$ 11.4m
Daniel Bradbury
Independent Chairman of the Board12.2yrsUS$305.95k0.078%
$ 621.4k
G. Cole
Independent Director5.9yrsUS$289.20k0.047%
$ 378.2k
Tiffany Olson
Independent Director3.5yrsUS$279.20k0.062%
$ 490.3k
Kenneth Aldape
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Howard Colman
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Kimberlee Caple
Independent Director3.3yrsUS$276.70k0.049%
$ 392.1k
Miles Harrison
Independent Director4.6yrsUS$285.45k0.047%
$ 378.2k
Ellen Goldberg
Independent Director3.3yrsUS$274.20k0.066%
$ 528.6k
Rodney Cotton
Independent Directorless than a year데이터 없음데이터 없음

4.0yrs

평균 재임 기간

62.5yo

평균 연령

경험이 풍부한 이사회: CSTL 의 이사회는 경험(평균 재직 기간 4 년)으로 간주됩니다.